Cargando…
Assessment of a demonstrator repository for individual clinical trial data built upon DSpace
Background: Given the increasing number and heterogeneity of data repositories, an improvement and harmonisation of practice within repositories for clinical trial data is urgently needed. The objective of the study was to develop and evaluate a demonstrator repository, using a widely used repositor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268148/ https://www.ncbi.nlm.nih.gov/pubmed/32528663 http://dx.doi.org/10.12688/f1000research.23468.2 |
_version_ | 1783541554921603072 |
---|---|
author | Tilki, Birol Schulenberg, Thomas Canham, Steve Banzi, Rita Kuchinke, Wolfgang Ohmann, Christian |
author_facet | Tilki, Birol Schulenberg, Thomas Canham, Steve Banzi, Rita Kuchinke, Wolfgang Ohmann, Christian |
author_sort | Tilki, Birol |
collection | PubMed |
description | Background: Given the increasing number and heterogeneity of data repositories, an improvement and harmonisation of practice within repositories for clinical trial data is urgently needed. The objective of the study was to develop and evaluate a demonstrator repository, using a widely used repository system (DSpace), and then explore its suitability for providing access to individual participant data (IPD) from clinical research. Methods: After a study of the available options, DSpace (version 6.3) was selected as the software for developing a demonstrator implementation of a repository for clinical trial data. In total, 19 quality criteria were defined, using previous work assessing clinical data repositories as a guide, and the demonstrator implementation was then assessed with respect to those criteria. Results: Generally, the performance of the DSpace demonstrator repository in supporting sensitive personal data such as that from clinical trials was strong, with 14 requirements demonstrated (74%), including the necessary support for metadata and identifiers. Two requirements could not be demonstrated (the ability to include de-identification tools and the availabiltiy of a self-attestation system) and three requirements were only partially demonstrated (ability to provide links to de-identification tools and requirements, incorporation of a data transfer agreement in system workflow, and capability to offer managed access through application on a case by case basis). Conclusions: Technically, the system was able to support most of the pre-defined requirements, though there are areas where support could be improved. Of course, in a productive repository, appropriate policies and procedures would be needed to direct the use of the available technical features. A technical evaluation should therefore be seen as indicating a system’s potential, rather than being a definite assessment of its suitability. DSpace clearly has considerable potential in this context and appears a suitable base for further exploration of the issues around storing sensitive data. |
format | Online Article Text |
id | pubmed-7268148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-72681482020-06-10 Assessment of a demonstrator repository for individual clinical trial data built upon DSpace Tilki, Birol Schulenberg, Thomas Canham, Steve Banzi, Rita Kuchinke, Wolfgang Ohmann, Christian F1000Res Research Article Background: Given the increasing number and heterogeneity of data repositories, an improvement and harmonisation of practice within repositories for clinical trial data is urgently needed. The objective of the study was to develop and evaluate a demonstrator repository, using a widely used repository system (DSpace), and then explore its suitability for providing access to individual participant data (IPD) from clinical research. Methods: After a study of the available options, DSpace (version 6.3) was selected as the software for developing a demonstrator implementation of a repository for clinical trial data. In total, 19 quality criteria were defined, using previous work assessing clinical data repositories as a guide, and the demonstrator implementation was then assessed with respect to those criteria. Results: Generally, the performance of the DSpace demonstrator repository in supporting sensitive personal data such as that from clinical trials was strong, with 14 requirements demonstrated (74%), including the necessary support for metadata and identifiers. Two requirements could not be demonstrated (the ability to include de-identification tools and the availabiltiy of a self-attestation system) and three requirements were only partially demonstrated (ability to provide links to de-identification tools and requirements, incorporation of a data transfer agreement in system workflow, and capability to offer managed access through application on a case by case basis). Conclusions: Technically, the system was able to support most of the pre-defined requirements, though there are areas where support could be improved. Of course, in a productive repository, appropriate policies and procedures would be needed to direct the use of the available technical features. A technical evaluation should therefore be seen as indicating a system’s potential, rather than being a definite assessment of its suitability. DSpace clearly has considerable potential in this context and appears a suitable base for further exploration of the issues around storing sensitive data. F1000 Research Limited 2020-06-25 /pmc/articles/PMC7268148/ /pubmed/32528663 http://dx.doi.org/10.12688/f1000research.23468.2 Text en Copyright: © 2020 Tilki B et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tilki, Birol Schulenberg, Thomas Canham, Steve Banzi, Rita Kuchinke, Wolfgang Ohmann, Christian Assessment of a demonstrator repository for individual clinical trial data built upon DSpace |
title | Assessment of a demonstrator repository for individual clinical trial data built upon DSpace |
title_full | Assessment of a demonstrator repository for individual clinical trial data built upon DSpace |
title_fullStr | Assessment of a demonstrator repository for individual clinical trial data built upon DSpace |
title_full_unstemmed | Assessment of a demonstrator repository for individual clinical trial data built upon DSpace |
title_short | Assessment of a demonstrator repository for individual clinical trial data built upon DSpace |
title_sort | assessment of a demonstrator repository for individual clinical trial data built upon dspace |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268148/ https://www.ncbi.nlm.nih.gov/pubmed/32528663 http://dx.doi.org/10.12688/f1000research.23468.2 |
work_keys_str_mv | AT tilkibirol assessmentofademonstratorrepositoryforindividualclinicaltrialdatabuiltupondspace AT schulenbergthomas assessmentofademonstratorrepositoryforindividualclinicaltrialdatabuiltupondspace AT canhamsteve assessmentofademonstratorrepositoryforindividualclinicaltrialdatabuiltupondspace AT banzirita assessmentofademonstratorrepositoryforindividualclinicaltrialdatabuiltupondspace AT kuchinkewolfgang assessmentofademonstratorrepositoryforindividualclinicaltrialdatabuiltupondspace AT ohmannchristian assessmentofademonstratorrepositoryforindividualclinicaltrialdatabuiltupondspace |